Xylitol Toxicosis in Dogs: Clinical Management

Bottom line

Xylitol is a potent canine insulin secretagogue: ingestions ≥ ~0.1 g/kg cause rapid, dose-dependent hypoglycemia, and ≥ ~0.5 g/kg can produce acute hepatic necrosis and coagulopathy [1][2][5]. There is no antidote and no bedside xylitol assay — treat on estimated dose. Manage symptomatic hypoglycemia with IV dextrose (bolus then CRI) and monitor blood glucose q1–2h for at least 12 h, and liver enzymes q24h for 72 h, because onset can be delayed [5]. Prognosis is excellent for uncomplicated hypoglycemia but guarded once hepatic failure or coagulopathy develops [2][3].

Clinical facts

• Hypoglycemic dose: ≥ ~0.1 g/kg (100 mg/kg) — rapid, dose-dependent insulin release [4][5].
• Hepatotoxic dose: ≥ ~0.5 g/kg (500 mg/kg) — acute hepatic necrosis / failure [2][5].
• Onset of hypoglycemia: usually 30–60 min, but delayed up to 12–18 h, especially with gum (delayed gastric emptying) [5][6].
• Onset of hepatic injury: enzyme elevation by 4–12 h; clinical liver signs typically ≥24–48 h [2][5].
• Species: dogs affected; cats and ferrets are not at risk [6].
• Activated charcoal: does NOT appreciably bind xylitol — not recommended [5].
• Prognosis: excellent for uncomplicated hypoglycemia; guarded for hepatic necrosis (~62% of dogs with clinical liver injury died or were euthanized in one case series) [2][5].

Mechanism and dose thresholds

Xylitol drives insulin secretion in dogs up to several-fold more strongly than an equivalent glucose load, producing rapid, dose-dependent hypoglycemia [1][5]; this species specificity is why dogs — and, to a lesser degree, rabbits — are at risk while cats, ferrets, and humans are not [6]. As of 2026, the working thresholds derived from ASPCA APCC data and the primary literature are ≥ ~0.1 g/kg (100 mg/kg) for hypoglycemia and ≥ ~0.5 g/kg (500 mg/kg) for hepatic injury [4][5]. Dose your risk assessment from the ingested amount, not from whether the dog is symptomatic on arrival — a normoglycemic dog above threshold still warrants monitoring.

Hepatic injury is dose-dependent but mechanistically distinct from the insulin effect and is incompletely understood. The prevailing hypotheses are prolonged hepatocellular ATP depletion during xylitol metabolism and generation of reactive oxygen species, either of which can drive centrilobular-to-massive hepatic necrosis [2]. Necropsy in the seminal eight-dog series showed severe hepatic necrosis or hepatocyte loss with lobular collapse [2]. Importantly, hepatotoxicity can occur with or without a preceding hypoglycemic crisis, so a dog that ingested a hepatotoxic dose but never dropped its glucose is not out of danger.

Sources and toxicokinetics

Sugar-free chewing gum is the most common culprit and the hardest to dose, because per-piece xylitol content varies widely by product, so estimate the dose from the product label — even a few pieces can exceed the hepatotoxic threshold in a small dog [6]. Always try to estimate total ingested xylitol: identify the product, its xylitol content per unit, and the count consumed. When per-piece content is unknown, assume a high-content product and treat toward the worst-case dose.

Beyond gum, xylitol appears in mints and candies, baked goods, peanut and nut butters marketed as "no sugar added," "keto"/sugar-free foods, chewable vitamins and supplements, toothpastes and dental products, and pharmaceutical vehicles — including some liquid medication formulations (e.g., certain compounded or syrup preparations) [5]. Absorption is rapid, and hypoglycemia typically begins within 30–60 minutes; however, onset is delayed up to 12–18 hours when xylitol is carried in a slowly emptying substrate such as gum [5][6]. This delayed-onset property is the single most important toxicokinetic point for triage: a normoglycemic gum-ingesting dog at hour 1 is not cleared.

Clinical signs and diagnosis

Diagnosis is made from history plus clinical picture plus serial blood glucose — there is no rapid confirmatory xylitol assay in practice, so treat on exposure and estimated dose [5]. Early hypoglycemic signs are vomiting, weakness, lethargy, ataxia, and, as glucose falls, collapse and seizures; hypokalemia may accompany the insulin surge [1][5]. In the DuHadway multicenter series of 192 dogs, vomiting and lethargy were the most common presenting signs, about 16% became hypoglycemic (glucose ≤60 mg/dL) at some point during hospitalization, and a similar fraction developed increased liver enzymes or bilirubin [3].

Hepatic injury declares later. Expect ALT/AST elevation detectable from roughly 4–12 hours, with clinical signs of hepatic insufficiency at ≥24–48 hours [2][5]. The full hepatotoxic syndrome, documented in the eight-dog JAVMA series, includes markedly elevated liver enzymes, hyperbilirubinemia, hyperphosphatemia, prolonged PT/PTT, thrombocytopenia, and petechial, ecchymotic, or GI hemorrhage [2]. Hyperphosphatemia was among the laboratory abnormalities reported in the eight-dog series [2]. Baseline and serial chemistry, coagulation panel, and electrolytes (potassium, phosphorus) frame both risk and trajectory.

Decontamination — and why activated charcoal is not recommended

Induce emesis only when ingestion is very recent AND the dog is still asymptomatic and normoglycemic; because xylitol is absorbed quickly, the window is narrow [5]. Do NOT induce emesis in a dog that is already hypoglycemic, weak, seizing, or otherwise compromised — the aspiration risk and the stress of vomiting outweigh any benefit. Confirm a normal blood glucose before decontamination and correct hypoglycemia first if present.

Activated charcoal does NOT appreciably bind xylitol and is not recommended — this is a common and consequential error, because giving charcoal offers no meaningful adsorption while adding aspiration risk [5]. Skip it and move directly to glucose stabilization, monitoring, and hepatic support. The mainstay of management is not decontamination but supportive care driven by serial blood glucose and liver monitoring.

Treatment: dextrose and hepatic support

For symptomatic hypoglycemia, give standard supportive dosing — an IV bolus of roughly 0.5–1 mL/kg of 50% dextrose (diluted at least 1:2–1:4, to ~10–25%) administered slowly, then a 2.5–5% dextrose CRI in a balanced crystalloid, titrated to maintain euglycemia [7] (the Schmid & Hovda case used a 5% dextrose CRI [4]). Hypoglycemia can persist for 24 hours or more, so continue dextrose until a normal blood glucose is maintained without supplementation, then wean rather than stop abruptly [5]. Avoid overcorrecting: bolus dextrose can transiently re-trigger insulin release, so lean on the CRI and re-dose boluses only for symptomatic drops. At-risk but asymptomatic dogs above the hypoglycemic threshold still need scheduled glucose monitoring even if they never require dextrose, because of delayed onset [5][6].

For hepatotoxic doses or any dog showing rising liver enzymes, layer in hepatoprotection. Representative regimens combine standard N-acetylcysteine dosing (a 140 mg/kg IV/PO loading dose, then 70 mg/kg q6h for several doses [7]), S-adenosylmethionine (SAMe, ~18–20 mg/kg PO q24h), and silymarin/milk thistle; these were used in the Chihuahua that ingested ~45 g/kg (nearly 100× the hepatotoxic threshold) and survived with full recovery (the Schmid & Hovda case used 121 mg/kg then 60 mg/kg q4h [4]) [5]. Efficacy of hepatoprotectants for xylitol specifically is not established, so treat them as adjuncts, not substitutes for glucose control and monitoring. For coagulopathy, give vitamin K1 (phytonadione) and fresh frozen plasma to replace clotting factors and control hemorrhage, as in the published survivor cases [2][4]. Note that most of these doses are extrapolated or off-label for this indication.

Monitoring and prognosis

Monitor blood glucose every 1–2 hours for at least 12 hours in any dog above the hypoglycemic threshold, and evaluate liver enzymes every 24 hours for at least 72 hours in any dog at or above the hepatotoxic threshold — even if it looks well early — because both hypoglycemia and hepatic injury can be delayed [5]. Track potassium and phosphorus alongside glucose (hypokalemia during insulin-driven hypoglycemia; hyperphosphatemia, which can accompany hepatic necrosis), and follow PT/PTT, platelets, and bilirubin when liver injury is suspected [2][5]. Reasonable discharge criteria for an uncomplicated case are a dog that maintains normoglycemia off dextrose through the delayed-onset window with liver values that stay normal on serial checks.

Prognosis is excellent for uncomplicated hypoglycemia treated promptly — all 192 dogs in the DuHadway series that did not develop liver failure survived to discharge [3][5]. It becomes guarded once acute hepatic necrosis and coagulopathy set in: in the original eight-dog series, five of eight died or were euthanized, and Merck cites ~62% mortality among dogs with clinical signs of liver injury despite aggressive care [2][5]. That said, survival is possible even after massive ingestion when dextrose, hepatoprotectants, vitamin K1, and plasma are applied early and aggressively [4]. Early, dose-driven triage — not waiting for symptoms — is what moves a high-dose ingestion from the guarded column toward recovery.

Frequently Asked Questions

What dose of xylitol causes hypoglycemia versus liver failure in dogs?

Hypoglycemia is expected at ingestions of roughly 0.1 g/kg (100 mg/kg) or more, driven by rapid dose-dependent insulin release, while acute hepatic necrosis and failure are associated with higher doses of about 0.5 g/kg (500 mg/kg) or more [2][4][5]. These thresholds derive from ASPCA APCC clinical data and the primary literature. Because hepatotoxicity can occur without a preceding hypoglycemic crisis, assess risk from the estimated ingested dose rather than from whether the dog is symptomatic on presentation [5][6].

Does activated charcoal bind xylitol?

No. Activated charcoal does not appreciably bind xylitol and is not recommended for xylitol ingestion [5]. Administering it provides no meaningful adsorption while adding aspiration risk, so it is a common but consequential error. Management should focus on glucose stabilization, serial monitoring, and hepatic support rather than decontamination adsorbents.

When should you induce emesis after xylitol ingestion?

Only when the ingestion is very recent and the dog is still asymptomatic and normoglycemic [5]. Confirm a normal blood glucose first, and do not induce emesis in a dog that is already hypoglycemic, weak, or seizing because of aspiration risk and the stress of vomiting. Given xylitol's rapid absorption, the useful window for emesis is narrow, and correcting hypoglycemia always takes priority over decontamination.

How long should you monitor blood glucose after xylitol ingestion?

Monitor blood glucose every 1–2 hours for at least 12 hours in any dog that ingested a hypoglycemic dose [5]. Onset can be delayed up to 12–18 hours, particularly with gum, so a normoglycemic dog early after ingestion is not cleared and asymptomatic at-risk dogs still need scheduled monitoring [5][6]. Continue dextrose support, if started, until normoglycemia is maintained without supplementation, then wean rather than stop abruptly.

Which hepatoprotectants are indicated for xylitol hepatotoxicity?

N-acetylcysteine, S-adenosylmethionine (SAMe), and silymarin/milk thistle are the agents used clinically, typically combined for dogs that ingested a hepatotoxic dose or that develop rising liver enzymes [4][5]. Representative dosing follows standard NAC regimens (a 140 mg/kg loading dose, then 70 mg/kg q6h) [7] and SAMe ~18–20 mg/kg q24h, with vitamin K1 and fresh frozen plasma added for coagulopathy [4]. Their specific efficacy against xylitol injury is not established, so they are adjuncts to glucose control and monitoring, and most dosing is extrapolated or off-label.

How do you estimate the xylitol dose from sugar-free gum?

Identify the specific gum product and its per-piece xylitol content, then multiply by the number of pieces ingested and divide by body weight [6]. Per-piece xylitol content varies widely by product, so estimate the dose from the product label — even a few pieces can exceed the hepatotoxic threshold in a small dog. When per-piece content is unknown, assume a high-content product and treat toward the worst-case dose.

What is the prognosis for xylitol toxicosis in dogs?

Excellent for uncomplicated hypoglycemia treated promptly — in a 192-dog series, all dogs that did not develop liver failure survived to discharge [3][5]. Prognosis becomes guarded once acute hepatic necrosis and coagulopathy develop; roughly 62% of dogs with clinical liver injury died or were euthanized in one dataset [2][5]. Survival is still possible after very large ingestions when dextrose, hepatoprotectants, vitamin K1, and plasma are applied early and aggressively [4].

Are cats or other species at risk from xylitol?

Cats and ferrets are not at risk of xylitol toxicosis, and the syndrome is essentially a canine problem [6]. Rabbits can experience similar insulin-driven effects, and a few other species show lesser responses, but the clinically relevant patient is the dog [6]. This species specificity reflects xylitol's uniquely strong insulinotropic effect in dogs, which is absent in cats and humans.